Literature DB >> 25457275

Clinical mesenchymal stromal cell products undergo functional changes in response to freezing.

Kathryn Pollock1, Darin Sumstad2, Diane Kadidlo2, David H McKenna2, Allison Hubel3.   

Abstract

BACKGROUND AIMS: Current methods of mesenchymal stromal cell (MSC) cryopreservation result in variable post-thaw recovery and phenotypic changes caused by freezing. The objective of this investigation was to determine the influence of ex vivo cell expansion on phenotype of MSCs and the response of resulting phenotypes to freezing and thawing.
METHODS: Human bone marrow aspirate was used. MSCs were isolated and cells were assessed for total count, viability, apoptosis and senescence over 6 passages (8-10 doublings/passage) in ex vivo culture. One half of cells harvested at each passage were re-plated for continued culture and the other half were frozen at 1°C/min in a controlled-rate freezer. Frozen samples were stored in liquid nitrogen, thawed and reassessed for total cell count, viability and senescence immediately and 48 h after thaw.
RESULTS: Viability did not differ significantly between samples before freeze or after thaw. Senescence increased over time in pre-freeze culture and was significantly higher in one sample that had growth arrest both before freeze and after thaw. Freezing resulted in similar initial post-thaw recovery in all samples, but 48-h post-thaw growth arrest was observed in the sample with high senescence only.
CONCLUSIONS: High pre-freeze senescence appears to correlate with poor post-thaw function in MSC samples, but additional studies are necessary to obtain a sample sizes large enough to quantify results.
Copyright © 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  apoptosis; freezing; function; mesenchymal stromal cells; senescence; viability

Mesh:

Year:  2014        PMID: 25457275      PMCID: PMC4274232          DOI: 10.1016/j.jcyt.2014.06.008

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  22 in total

1.  Advancing the preservation of cellular therapy products.

Authors:  Allison Hubel
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

2.  Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells.

Authors:  Luc Sensebé; Karin Tarte; Jacques Galipeau; Mauro Krampera; Ivan Martin; Donald G Phinney; Yufang Shi
Journal:  Cell Stem Cell       Date:  2012-01-06       Impact factor: 24.633

3.  Comparative cellular and molecular analyses of pooled bone marrow multipotent mesenchymal stromal cells during continuous passaging and after successive cryopreservation.

Authors:  Murali Krishna Mamidi; Kavitha Ganesan Nathan; Gurbind Singh; Saratha Thevi Thrichelvam; Nurul Ain Nasim Mohd Yusof; Noor Atiqah Fakharuzi; Zubaidah Zakaria; Ramesh Bhonde; Anjan Kumar Das; Anish Sen Majumdar
Journal:  J Cell Biochem       Date:  2012-10       Impact factor: 4.429

4.  Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation.

Authors:  S P Bruder; N Jaiswal; S E Haynesworth
Journal:  J Cell Biochem       Date:  1997-02       Impact factor: 4.429

5.  Cryobiophysical characteristics of genetically modified hematopoietic progenitor cells.

Authors:  A Hubel; J Norman; T B Darr
Journal:  Cryobiology       Date:  1999-03       Impact factor: 2.487

6.  A Saccharomyces cerevisiae cell-based quantitative beta-galactosidase assay compatible with robotic handling and high-throughput screening.

Authors:  Rogerio Alves de Almeida; Danielle Burgess; Reut Shema; Nuzhat Motlekar; Andrew D Napper; Scott L Diamond; Graham D Pavitt
Journal:  Yeast       Date:  2008-01       Impact factor: 3.239

7.  How to track cellular aging of mesenchymal stromal cells?

Authors:  Wolfgang Wagner; Simone Bork; Günther Lepperdinger; Sylvia Joussen; Nan Ma; Dirk Strunk; Carmen Koch
Journal:  Aging (Albany NY)       Date:  2010-04       Impact factor: 5.682

8.  Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion.

Authors:  Melissa A Baxter; Robert F Wynn; Simon N Jowitt; J Ed Wraith; Leslie J Fairbairn; Ilaria Bellantuono
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

9.  An in vitro expansion score for tissue-engineering applications with human bone marrow-derived mesenchymal stem cells.

Authors:  Alessandro Bertolo; Marco Mehr; Tiziana Janner-Jametti; Ursula Graumann; Niklaus Aebli; Martin Baur; Stephen J Ferguson; Jivko V Stoyanov
Journal:  J Tissue Eng Regen Med       Date:  2013-04-10       Impact factor: 3.963

10.  Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing.

Authors:  Moïra François; Ian B Copland; Shala Yuan; Raphaëlle Romieu-Mourez; Edmund K Waller; Jacques Galipeau
Journal:  Cytotherapy       Date:  2011-10-27       Impact factor: 5.414

View more
  22 in total

1.  Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFNγ priming.

Authors:  Raghavan Chinnadurai; Devi Rajan; Spencer Ng; Kenneth McCullough; Dalia Arafat; Edmund K Waller; Larry J Anderson; Greg Gibson; Jacques Galipeau
Journal:  Blood Adv       Date:  2017-04-25

2.  Enhanced viability and neural differential potential in poor post-thaw hADSCs by agarose multi-well dishes and spheroid culture.

Authors:  Xiaoling Guo; Shanyi Li; Qingshan Ji; Ruiling Lian; Jiansu Chen
Journal:  Hum Cell       Date:  2015-06-09       Impact factor: 4.174

3.  Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach.

Authors:  Raghavan Chinnadurai; Devi Rajan; Muna Qayed; Dalia Arafat; Marco Garcia; Yifei Liu; Subra Kugathasan; Larry J Anderson; Greg Gibson; Jacques Galipeau
Journal:  Cell Rep       Date:  2018-02-27       Impact factor: 9.423

Review 4.  Mesenchymal Stromal Cell Therapy in Spinal Cord Injury: Mechanisms and Prospects.

Authors:  Ji-Le Xie; Xing-Ran Wang; Mei-Mei Li; Zi-Han Tao; Wen-Wen Teng
Journal:  Front Cell Neurosci       Date:  2022-06-03       Impact factor: 6.147

5.  Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing.

Authors:  Raghavan Chinnadurai; Ian B Copland; Marco A Garcia; Christopher T Petersen; Christopher N Lewis; Edmund K Waller; Allan D Kirk; Jacques Galipeau
Journal:  Stem Cells       Date:  2016-07-04       Impact factor: 6.277

6.  In vitro cytokine licensing induces persistent permissive chromatin at the Indoleamine 2,3-dioxygenase promoter.

Authors:  Yazmin I Rovira Gonzalez; Patrick J Lynch; Elaine E Thompson; Brian G Stultz; Deborah A Hursh
Journal:  Cytotherapy       Date:  2016-07-12       Impact factor: 5.414

7.  Algorithm-driven optimization of cryopreservation protocols for transfusion model cell types including Jurkat cells and mesenchymal stem cells.

Authors:  Kathryn Pollock; Joseph W Budenske; David H McKenna; Peter I Dosa; Allison Hubel
Journal:  J Tissue Eng Regen Med       Date:  2016-05-27       Impact factor: 3.963

8.  Freezing Responses in DMSO-Based Cryopreservation of Human iPS Cells: Aggregates Versus Single Cells.

Authors:  Rui Li; Guanglin Yu; Samira M Azarin; Allison Hubel
Journal:  Tissue Eng Part C Methods       Date:  2018-03-28       Impact factor: 3.056

Review 9.  MSCs and Inflammatory Cells Crosstalk in Regenerative Medicine: Concerted Actions for Optimized Resolution Driven by Energy Metabolism.

Authors:  Valerie Planat-Benard; Audrey Varin; Louis Casteilla
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

10.  Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match.

Authors:  Jayeeta Giri; Jacques Galipeau
Journal:  Blood Adv       Date:  2020-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.